GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhaoke Ophthalmology Ltd (HKSE:06622) » Definitions » Gross Margin %

Zhaoke Ophthalmology (HKSE:06622) Gross Margin % : 54.97% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Zhaoke Ophthalmology Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Zhaoke Ophthalmology's Gross Profit for the six months ended in Dec. 2023 was HK$4.48 Mil. Zhaoke Ophthalmology's Revenue for the six months ended in Dec. 2023 was HK$8.14 Mil. Therefore, Zhaoke Ophthalmology's Gross Margin % for the quarter that ended in Dec. 2023 was 54.97%.


The historical rank and industry rank for Zhaoke Ophthalmology's Gross Margin % or its related term are showing as below:

HKSE:06622' s Gross Margin % Range Over the Past 10 Years
Min: 75.98   Med: 75.98   Max: 75.99
Current: 75.99


During the past 5 years, the highest Gross Margin % of Zhaoke Ophthalmology was 75.99%. The lowest was 75.98%. And the median was 75.98%.

HKSE:06622's Gross Margin % is ranked better than
69.73% of 750 companies
in the Biotechnology industry
Industry Median: 60.88 vs HKSE:06622: 75.99

Zhaoke Ophthalmology had a gross margin of 54.97% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Zhaoke Ophthalmology was 0.00% per year.


Zhaoke Ophthalmology Gross Margin % Historical Data

The historical data trend for Zhaoke Ophthalmology's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhaoke Ophthalmology Gross Margin % Chart

Zhaoke Ophthalmology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
- - - - 75.98

Zhaoke Ophthalmology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only - - - 89.83 54.97

Competitive Comparison of Zhaoke Ophthalmology's Gross Margin %

For the Biotechnology subindustry, Zhaoke Ophthalmology's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhaoke Ophthalmology's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhaoke Ophthalmology's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Zhaoke Ophthalmology's Gross Margin % falls into.



Zhaoke Ophthalmology Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Zhaoke Ophthalmology's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=15.6 / 20.508
=(Revenue - Cost of Goods Sold) / Revenue
=(20.508 - 4.925) / 20.508
=75.98 %

Zhaoke Ophthalmology's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=4.5 / 8.144
=(Revenue - Cost of Goods Sold) / Revenue
=(8.144 - 3.667) / 8.144
=54.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Zhaoke Ophthalmology  (HKSE:06622) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Zhaoke Ophthalmology had a gross margin of 54.97% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Zhaoke Ophthalmology Gross Margin % Related Terms

Thank you for viewing the detailed overview of Zhaoke Ophthalmology's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhaoke Ophthalmology (HKSE:06622) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangdong Province, Guangzhou, CHN
Zhaoke Ophthalmology Ltd is an ophthalmic pharmaceutical company. It is dedicated to the research, development, and commercialization of therapies that address unmet medical needs in China. The company has built a comprehensive ophthalmic drug pipeline of 26 candidates that covers ocular indications affecting the front and the back of the eye, through either in-house development or in-licensing. It has also established an ophthalmic manufacturing facility and is assembling an experienced marketing team in anticipation of a near-term product launch.
Executives
Mak Siu Hang Viola 2201 Interest of corporation controlled by you
Apstar Investment Pte Ltd 2201 Interest of corporation controlled by you
Coyote Investment Pte Ltd 2101 Beneficial owner
Gic (ventures) Pte. Ltd. 2201 Interest of corporation controlled by you
Gic Special Investments Private Limited 2102 Investment manager
Gic Private Limited 2201 Interest of corporation controlled by you
Fidelity China Special Situations Plc 2101 Beneficial owner
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Citigroup Inc. 2502 Approved lending agent
Vms Holdings Limited 2201 Interest of corporation controlled by you
Lee's Pharmaceutical Holdings Limited 2201 Interest of corporation controlled by you
Tpg Asia Genpar Vii, L.p. 2201 Interest of corporation controlled by you
Tpg Holdings Iii-a, L.p. 2201 Interest of corporation controlled by you

Zhaoke Ophthalmology (HKSE:06622) Headlines

No Headlines